Filter by Category:

Clinical AJCC Stage

AJCC Clinical stage is the extent of disease defined by diagnostic study before information is available from surgical resection or neoadjuvant treatment.  The clinical stage incorporates information obtained from symptoms; physical examination; endoscopic examination; imaging studies; biopsies; and surgical exploration without resection.  A blank clinical stage is used only when this criteria is not met; there is no information whatsoever in the EMR; or there was…

Posted on Jul. 29, 2016 in How Should I Code This?

Skin Cancer Prevention

Summer equals fun in the sun with family and friends!  I recently spent a week with family and planned outings to the beach, the aquatic center, parks, a petting zoo, and hours playing outside.   I was exhausted but the children had a great week and many memories to share.  I recognize a significant change from ten or twenty years ago that was encouraging to me as…

Posted on Jul. 25, 2016 in From Our Perspective

Consultant Spotlight: Roberta Adams, CTR

Roberta Adams, CTR is a Quality Control Manager with the Registry Partners Oncology Services Division.  She began working with Registry Partners as a Project CTR in November of 2015 before transitioning to Project Manager in March, and subsequently her current role as Quality Control Manager in June of this year. Roberta attended Arkansas Tech University – Ozark Campus where she received her Associate’s degree in Business…

Posted on Jul. 18, 2016 in Consultant Spotlight

SEER Summary Staging Manual 2000

SEER Summary Stage is required to be directly coded by most state registries.  See below for definitions and helpful tips when assigning the SEER Summary Stage. In situ (code 0) = The presence of malignant cells within the cell group from which they arose.  There is no penetration of the basement membrane of the tissue and no stromal invasion Localized (code 1) = A malignancy limited…

Posted on Jul. 15, 2016 in How Should I Code This?